Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Prepaid Assets (2016 - 2025)

Dare Bioscience's Prepaid Assets history spans 8 years, with the latest figure at $2.4 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 14.44% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $2.4 million, down 14.44%, while the annual FY2025 figure was $2.4 million, 14.44% down from the prior year.
  • Prepaid Assets reached $2.4 million in Q4 2025 per DARE's latest filing, up from $53159.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $6.9 million in Q3 2022 to a low of $53159.0 in Q3 2025.
  • Average Prepaid Assets over 5 years is $3.4 million, with a median of $2.6 million recorded in 2021.
  • Peak YoY movement for Prepaid Assets: soared 2290.49% in 2024, then crashed 98.34% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $2.5 million in 2021, then soared by 169.16% to $6.7 million in 2022, then fell by 8.22% to $6.1 million in 2023, then crashed by 55.06% to $2.7 million in 2024, then fell by 14.44% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for DARE's Prepaid Assets are $2.4 million (Q4 2025), $53159.0 (Q3 2025), and $1.4 million (Q2 2025).